STUDY OF CLINICOPATHOLOGICAL PROFILE AND OUTCOMES OF PATIENTS WITH INFECTION RELATED GLOMERULONEPHRITIS FROM A SINGLE TERTIARY CENTRE IN SOUTHERN INDIA

 
STUDY OF CLINICOPATHOLOGICAL PROFILE AND OUTCOMES OF PATIENTS WITH INFECTION RELATED GLOMERULONEPHRITIS FROM A SINGLE TERTIARY CENTRE IN SOUTHERN INDIA
K J PRIYADARSHINI
JOHN
Dr Manisha Sahay drmanishasahay@gmail.com OSMANIA GENERAL HOSPITAL Nephrology hyderabad
Dr Vinant Bhargava vinant.bhargava@gmail.com SRI GANGARAM HOSPITAL NEPHROLOGY NEW DELHI
 
 
 
 
 
 
 
 
 
 
 
 
 

Changing epidemiology of Infection related glomerulonephritis from an indolent course into more dramatic presentation and outcomes conferred newer insights to the prevailing pathogenesis and pathophysiology. In the yester years, IRGN was mostly limited to children and was considered to be benign secondary to streptococcal respiratory tract and skin infection. As the time elapsed, we see staphylococcal infections as the most common culprit, more so in adults in whom the presentation and outcomes sometimes are gloomy. In adults’ various factors implicated in causation of IRGN diabetes mellitus, malignancy, alcoholism and intravenous drug abuse.

In this context, this study is undertaken to study the epidemiology, clinical presentation, various spectrum of infections and outcomes of IRGN. Institutional ethical committee clearance is taken .The current study is both retrospective and prospective data collected from August 2022 to February 2023 from patients presented with features consistent with IRGN. Renal biopsy is done in cases of rapidly progressive renal failure or persistent nephrotic proteinuria. Evaluation for underlying possible source of infection are documented. Laboratory evaluation, apart from routine blood chemistry, specific investigations include Complement levels, blood culture, urine culture, dental examination, ENT evaluation, bone and musculoskeletal screening in relevant cases, 2DEcho, fever profile, ASO titers, fundus examination, serology for HIV, HBsAg and HCV and other tropical infections like Dengue, Leptospira, Malaria and scrub. Data regarding the treatment, need for renal replacement therapy are collected.Patients are followed post discharge at 1 month, 3 months and 6 months. Hypertension, renal dysfunction, proteinuria, complement levels and active sediment are assessed during the time of follow up.

Data is captulated. Final data will be presented in the WCN congress.

Quesstionairre

QUESTIONAIRE

 

Name

Age

Gender

Occupation

Resident of

Phone

History of     Fever/hematuria/sore throat/skin lesions/dental caries/oliguria/hypertension/edema

Other systems- rash, joint pains, diarrhea, jaundice, seizures, bleeding

Family history of similar illness

Epidemic or sporadic onset

Clinical syndrome Nephrotic-nephritic/ Acute Nephritic illness/       RPRF /AKI

Co Morbidities HTN/DM/CAD/TB/IV Drug abuse/ Malignancy

Investigations

CBP

CRP

RFT

LFT

LDH

ESR

24 hr protein

UPCR

CUE

ASO titres

Blood culture

Urine culture

Dental examination

ENT examination

Fundus

Fever profile (in relevant cases)- Smear for Malarial parasite, Dengue IgG and IgM; NS1; Leptospira antibodies; Scrub typus antibodies.

Complement levels (C3 and C4)

ANA and ANCA levels are done when relevant

CXR PA VIEW

USG

Renal biopsy

Renal replacement therapy

 

 

 

IRGN is a self limiting glomerulonephritis. Nevertheless timely follow up of cases help us understand the changing pathogenesis, pathophysiology and outcome of the patients with IRGN.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos